The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.
Go to Source
Author: Rebecca Robbins and Lauren Hirsch
https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml
-
-
Why has Trump attacked Venezuela and taken Maduro?
-
Swiss open criminal case against managers of ski resort bar after deadly fire
-
Trump warning over Iran protests ‘reckless’ says foreign minister
-
Israeli Government Accuses Mamdani of Antisemitism Over Canceled Orders
-
No Kings: Demonstrators Peacefully Take to the Streets Nationwide Protesting Against Trump
-
Zelenskyy Meets with Trump at White House
-
Former National Security Adviser John Bolton Indicted on 18 Charges
